Quick Takeaways
- Roger D. Dansey has 5 issuer positions tracked on this page.
- Estimated disclosed ownership value: $154,963.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Roger D. Dansey and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BCYC | BICYCLE THERAPEUTICS PLC | Director | $109,968 | 02 Jan 2026 | ||
| INO | INOVIO PHARMACEUTICALS, INC. | Director | $44,995 | 21 May 2025 | ||
| KRON | Kronos Bio, Inc. | Director | 20 Jun 2025 | |||
| NRIX | Nurix Therapeutics, Inc. | Director | 06 Nov 2025 | |||
| SGEN | Seagen Inc. | President, R&D & CMO | 14 Dec 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|